These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy. Nguyen MA; Joya JE; Kee AJ; Domazetovska A; Yang N; Hook JW; Lemckert FA; Kettle E; Valova VA; Robinson PJ; North KN; Gunning PW; Mitchell CA; Hardeman EC Brain; 2011 Dec; 134(Pt 12):3516-29. PubMed ID: 22067542 [TBL] [Abstract][Full Text] [Related]
4. Combined MRI and ³¹P-MRS investigations of the ACTA1(H40Y) mouse model of nemaline myopathy show impaired muscle function and altered energy metabolism. Gineste C; Le Fur Y; Vilmen C; Le Troter A; Pecchi E; Cozzone PJ; Hardeman EC; Bendahan D; Gondin J PLoS One; 2013; 8(4):e61517. PubMed ID: 23613869 [TBL] [Abstract][Full Text] [Related]
5. Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial Biology. Tinklenberg JA; Slick RA; Sutton J; Zhang L; Meng H; Beatka MJ; Vanden Avond M; Prom MJ; Ott E; Montanaro F; Heisner J; Toro R; Hardeman EC; Geurts AM; Stowe DF; Hill RB; Lawlor MW Am J Pathol; 2023 Oct; 193(10):1548-1567. PubMed ID: 37419385 [TBL] [Abstract][Full Text] [Related]
6. Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism. Gineste C; Duhamel G; Le Fur Y; Vilmen C; Cozzone PJ; Nowak KJ; Bendahan D; Gondin J PLoS One; 2013; 8(8):e72294. PubMed ID: 23977274 [TBL] [Abstract][Full Text] [Related]
7. Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function. Sztal TE; Zhao M; Williams C; Oorschot V; Parslow AC; Giousoh A; Yuen M; Hall TE; Costin A; Ramm G; Bird PI; Busch-Nentwich EM; Stemple DL; Currie PD; Cooper ST; Laing NG; Nowak KJ; Bryson-Richardson RJ Acta Neuropathol; 2015 Sep; 130(3):389-406. PubMed ID: 25931053 [TBL] [Abstract][Full Text] [Related]
8. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Ravenscroft G; Jackaman C; Bringans S; Papadimitriou JM; Griffiths LM; McNamara E; Bakker AJ; Davies KE; Laing NG; Nowak KJ Brain; 2011 Apr; 134(Pt 4):1101-15. PubMed ID: 21303860 [TBL] [Abstract][Full Text] [Related]
9. Dietary L-tyrosine supplementation in nemaline myopathy. Ryan MM; Sy C; Rudge S; Ellaway C; Ketteridge D; Roddick LG; Iannaccone ST; Kornberg AJ; North KN J Child Neurol; 2008 Jun; 23(6):609-13. PubMed ID: 18079309 [TBL] [Abstract][Full Text] [Related]
10. Defining alpha-skeletal and alpha-cardiac actin expression in human heart and skeletal muscle explains the absence of cardiac involvement in ACTA1 nemaline myopathy. Ilkovski B; Clement S; Sewry C; North KN; Cooper ST Neuromuscul Disord; 2005 Dec; 15(12):829-35. PubMed ID: 16288873 [TBL] [Abstract][Full Text] [Related]
18. Acute and chronic tirasemtiv treatment improves in vivo and in vitro muscle performance in actin-based nemaline myopathy mice. de Winter JM; Gineste C; Minardi E; Brocca L; Rossi M; Borsboom T; Beggs AH; Bernard M; Bendahan D; Hwee DT; Malik FI; Pellegrino MA; Bottinelli R; Gondin J; Ottenheijm CAC Hum Mol Genet; 2021 Jun; 30(14):1305-1320. PubMed ID: 33909041 [TBL] [Abstract][Full Text] [Related]
19. Morphological and functional alterations of neuromuscular synapses in a mouse model of ACTA1 congenital myopathy. Liu Y; Lin W Hum Mol Genet; 2024 Jan; 33(3):233-244. PubMed ID: 37883471 [TBL] [Abstract][Full Text] [Related]
20. Histopathologic progression and a novel mutation in a child with nemaline myopathy. Ladha S; Coons S; Johnsen S; Sambuughin N; Bien-Wilner R; Sivakumar K J Child Neurol; 2008 Jul; 23(7):813-7. PubMed ID: 18487519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]